The Hippo

HOME| ADVERTISING | CONTACT US|

» » »

Niacin for Statin Patients Nashua NH

Taking the B vitamin niacin offers no additional benefit to seniors with coronary artery disease who are already prescribed cholesterol-lowering statin drugs, U.S. researchers say. The 18-month study of 145 Baltimore-area men and women over age 65 found no measurable difference in arterial wall thickness reductions between those who took 1,500 milligrams a day of extended-release niacin plus a statin and those who took only a statin.

Steven Lee Schwartz, MD
(603) 577-2039
PO Box 1184
Nashua, NH
Specialties
Cardiology, Internal Medicine
Gender
Male
Education
Medical School: Suny-Hlth Sci Ctr At Brooklyn, Coll Of Med, Brooklyn Ny 11203
Graduation Year: 1984
Hospital
Hospital: Lahey Clinic, Burlington, Ma; Southern New Hampshire Regiona, Nashua, Nh
Group Practice: Lahey Cardiology

Data Provided by:
Dr.Yuka Endo
(603) 577-2039
8 Prospect Street
Nashua, NH
Gender
F
Speciality
Cardiologist
General Information
Accepting New Patients: Yes
RateMD Rating
1.0, out of 5 based on 1, reviews.

Data Provided by:
Yuka Endo, MD
(603) 549-7089
22 Bay Ridge Dr Apt L
Nashua, NH
Specialties
Cardiology
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Peter Sam Hacker
(603) 883-2226
30 Dearborn St
Nashua, NH
Specialty
General Practice, Cardiology

Data Provided by:
Mark Joel Liebling, MD
(603) 883-5673
166 Kinsley St Ste 301
Nashua, NH
Specialties
Cardiology
Gender
Male
Education
Medical School: A Einstein Coll Of Med Of Yeshiva Univ, Bronx Ny 10461
Graduation Year: 1975

Data Provided by:
Wendi A Cardeiro, MD, FACC
(603) 577-2039
PO Box 1184
Nashua, NH
Specialties
Cardiology
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Peter Tabor Klementowicz, MD
(603) 883-5673
166 Kinsley St Ste 301
Nashua, NH
Specialties
Cardiology
Gender
Male
Education
Medical School: Tufts Univ Sch Of Med, Boston Ma 02111
Graduation Year: 1978

Data Provided by:
Yuka Endo
(603) 577-2039
8 Prospect St # 1184
Nashua, NH
Specialty
Cardiovascular Disease

Data Provided by:
Paul Francis Boffetti
(603) 577-2780
8 Prospect St
Nashua, NH
Specialty
Cardiology, Internal Medicine

Data Provided by:
Dr.Steven Schwartz
(603) 577-2039
8 Prospect Street
Nashua, NH
Gender
M
Education
Medical School: Suny-Hlth Sci Ctr At Brooklyn, Coll Of Med
Year of Graduation: 1984
Speciality
Cardiologist
General Information
Hospital: Lahey Clinic, Burlington, Ma
Accepting New Patients: Yes
RateMD Rating
5.0, out of 5 based on 3, reviews.

Data Provided by:
Data Provided by:

Niacin for Statin Patients

Provided By:

WEDNESDAY, Nov. 18 (HealthDay News) -- Taking the B vitamin niacin offers no additional benefit to seniors with coronary artery disease who are already prescribed cholesterol-lowering statin drugs, U.S. researchers say.

The 18-month study of 145 Baltimore-area men and women over age 65 found no measurable difference in arterial wall thickness reductions between those who took 1,500 milligrams a day of extended-release niacin plus a statin and those who took only a statin.

Researchers from the Johns Hopkins University School of Medicine found the results were the same whether the patients took any of the three leading statin drugs: Lipitor (atorvastatin), Zocor (simvastatin) or Crestor (rosuvastatin).

Patients on the dual niacin/statin therapy had an average 5.4 cubic millimeter per month reduction in plaque buildup in the main neck (carotid) artery, compared with 4.0 cubic millimeters for those who took only a statin, which the study authors noted was not a statistically significant difference.

The study was scheduled to be presented Wednesday at the American Heart Association's annual meeting in Orlando, Fla.

"Our findings tell us that improved cholesterol levels from taking combination vitamin B niacin and statin therapy do not necessarily translate into observable benefits in reversing and stalling carotid artery disease," senior investigator and cardiologist Dr. Joao Lima said in a news release from Johns Hopkins. "This does not mean that niacin therapy may not have other cardiovascular benefits, but any such benefits are independent of reducing the amount of plaque buildup and patients should be aware of that," Lima explained.

"Our recommendation to physicians is that current national treatment guidelines, which recommend mainly statin therapy tailored to the severity of atherosclerosis for preventing arteries from reclogging and narrowing, appear to be sufficient and accurate for physicians and patients to follow," Lima added.

More information

The U.S. National Heart, Lung, and Blood Institute has more about coronary artery disease.

SOURCE: Johns Hopkins Medicine, news release, Nov. 18, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

®2010 Hippo Press. site by wedu